API
CDMO
About us
Products

Ruikangda Biomedical Technology

Ruikangda (Shandong) Biopharmaceutical Technology Co., Ltd. was established in 2023, headquartered in Liaocheng City, Shandong Province. The company originated from the raw material project of Shandong Ruisheng Pharmaceutical Excipients Co., Ltd. (Shandong Ruisheng Pharmaceutical Excipients Co., Ltd. was established in 2012 and is the largest and most comprehensive pharmaceutical excipient production enterprise in China). Ruikangda has the world's exclusive gene sequence with ultra-high enzyme activity. Ruikangda is the only manufacturer in the world that uses exclusive AI reasoning algorithms for gene screening, gene editing, gene expression, strain cultivation, enzyme production, and UDCA production. The company has 34 employees, including 2 PhDs and 5 masters, with an enzyme production capacity of 400 tons and a UDCA production capacity of 300 tons. It is the world's first enzyme tool...

Address: Huangshan Road, Jiuzhou Street, High-tech Zone, , Liaocheng City, Shandong Province
China
China Local time:

Ensures stability across batches from gene editing to enzyme and UDCA production

GMP standards compliance to ensure the lowest levels of single, total, and C impurities within the product category

Customized services, supplying enzymes for UDCA conversion and crude UDCA products with purity from 85% to 99.99%

Our clients:

All API Buyers

Our services:

API
Intermediates
Contract services

Response time:

Employees:
34
Established in:
2023
Number of products Number of products:
2

Latest updates

Ruikangda (Shandong) Biomedical Technology Co., Ltd.’s raw material drug ursodeoxycholic acid project (Phase I) Environmental Impact Report

Ruikangda (Shandong) Biomedical Technology Co., Ltd.’s raw material drug ursodeoxycholic acid project (Phase I) Environmental Impact Report

The environmental impact report (draft for comments) of the raw material drug ursodeoxycholic acid project (Phase I) of Ruikangda (Shandong) Biomedical Technology Co., Ltd. was completed. According to

Learn more
Ruikangda (Shandong) Biomedical Technology Co., Ltd. raw material drug ursodeoxycholic acid project (Phase I)

Ruikangda (Shandong) Biomedical Technology Co., Ltd. raw material drug ursodeoxycholic acid project (Phase I)

Ruikangda (Shandong) Biomedical Technology Co., Ltd. commissioned the preparation of the "Environmental Impact Report of the Raw Material Drug Ursodeoxycholic Acid Project of Ruikangda (Shandong)

Learn more

Where we are located

Our products

Filters

Reset current filters

Selected filters:

Type
Production region
Country of origin
Qualifications
Show more

Produced in:

China

MOQ: -

  • CoA

  • ISO9001

  • MSDS

  • BSE/TSE

Contact supplier

Replies quickly

Produced in:

China

MOQ: -

  • CoA

  • ISO9001

  • MSDS

  • BSE/TSE

Contact supplier

Replies quickly

Contact Ruikangda Biomedical Technology and get a competitive price offer.

Ruikangda Biomedical Technology is a supplier from China. They offer 2 products (APIs, Excipients or Intermediates). Contact Ruikangda Biomedical Technology for free and get a competitive price offer.

Find a price of UDCA Biocatalyst – 7α/7β-HSDH + LDH/GDH Cascade bulk with offered by Ruikangda Biomedical Technology.
Find a price of Ursodeoxycholic acid bulk with offered by Ruikangda Biomedical Technology.

Note that some products will only be visible after logging in.

Are you looking for pharmaceutical ingredients for the production of medicines? Contact the supplier of your choice by using the send inquiry button and find out how much it cost. The supplier will contact you with their price and conditions. Ruikangda Biomedical Technology replies quickly.

You can send an inquiry for these products. Some suppliers have set a minimum order quantity (moq). Provide enough information regarding your enquiry. Let Ruikangda Biomedical Technology know whether you are looking for Ph.Eur (EP), USP, BP, JP grade. Also, let the manufacturer or trader know if you are looking for hydrochloride (HCl), base or other product specifications. Is it for own production, resale or research purposes? Contact Ruikangda Biomedical Technology, get a price, download certificates and buy the product.

Ruikangda Biomedical Technology


Ruikangda (Shandong) Biopharmaceutical Technology Co., Ltd. was established in 2023, headquartered in Liaocheng City, Shandong Province. The company originated from the raw material project of Shandong Ruisheng Pharmaceutical Excipients Co., Ltd. (Shandong Ruisheng Pharmaceutical Excipients Co., Ltd. was established in 2012 and is the largest and most comprehensive pharmaceutical excipient production enterprise in China). Ruikangda has the world's exclusive gene sequence with ultra-high enzyme activity. Ruikangda is the only manufacturer in the world that uses exclusive AI reasoning algorithms for gene screening, gene editing, gene expression, strain cultivation, enzyme production, and UDCA production. The company has 34 employees, including 2 PhDs and 5 masters, with an enzyme production capacity of 400 tons and a UDCA production capacity of 300 tons. It is the world's first enzyme tool to transform UDCA through AI based gene screening, and its technology and scale are globally leading. The company has independent gene synthesis technology and enzyme synthesis workshop, with international advanced level in key core areas. Our genetically engineered strains are reduced in production costs through targeted modification of multi enzyme catalytic technology; Solved the problems of high cost and long reaction steps for bear removal, enabling us to The purity and other key indicators of the product have reached a global leading level.